Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CytomX Therapeutics, Inc. | 31,898 | reported | 20 Jul 2022 | tx 8+667,500−5,602 |
| NEOGENOMICS INC | 23,077 | reported | 01 Jun 2025 | tx 40+294,068−59,145 |
| RIGEL PHARMACEUTICALS INC | 16,375 | reported | 15 May 2026 | tx 12+270,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 May 2026 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 5,750 | 0.00 USD | |
| 01 Jun 2025 | GRANT_AWARD | NEOGENOMICS INC | 12,254 | 0.00 USD | |
| 01 Jun 2025 | EXERCISE | NEOGENOMICS INC | 12,254 | 0.00 USD | deriv |
| 01 Jun 2025 | GRANT_AWARD | NEOGENOMICS INC | 23,077 | 0.00 USD | deriv |
| 01 Jun 2025 | GRANT_AWARD | NEOGENOMICS INC | 16,107 | 0.00 USD | deriv |
| 23 May 2025 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 2,500 | 0.00 USD | |
| 23 May 2025 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 3,000 | 0.00 USD | deriv |
| 10 Aug 2024 | EXERCISE | NEOGENOMICS INC | 11,336 | 0.00 USD | |
| 10 Aug 2024 | EXERCISE | NEOGENOMICS INC | 11,336 | 0.00 USD | deriv |
| 01 Jun 2024 | GRANT_AWARD | NEOGENOMICS INC | 12,254 | 0.00 USD | deriv |
| 01 Jun 2024 | GRANT_AWARD | NEOGENOMICS INC | 8,672 | 0.00 USD | deriv |
| 25 May 2024 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 25,000 | 0.00 USD | |
| 25 May 2024 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 30,000 | 0.00 USD | deriv |
| 10 Aug 2023 | GRANT_AWARD | NEOGENOMICS INC | 8,353 | 0.00 USD | deriv |
| 10 Aug 2023 | GRANT_AWARD | NEOGENOMICS INC | 11,336 | 0.00 USD | deriv |
| 26 May 2023 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 25,000 | 0.00 USD | |
| 26 May 2023 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 30,000 | 0.00 USD | deriv |
| 19 Jul 2022 | GRANT_AWARD | CytomX Therapeutics, Inc. | 15,000 | 0.00 USD | |
| 20 Jul 2022 | SALE | CytomX Therapeutics, Inc. | 5,602 | 1.42 USD | |
| 10 Jun 2022 | GRANT_AWARD | NEOGENOMICS INC | 15,556 | 0.00 USD | |
| 10 Jun 2022 | GRANT_AWARD | NEOGENOMICS INC | 13,882 | 0.00 USD | deriv |
| 20 May 2022 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 25,000 | 0.00 USD | |
| 20 May 2022 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 30,000 | 0.00 USD | deriv |
| 02 Feb 2022 | GRANT_AWARD | CytomX Therapeutics, Inc. | 22,500 | 0.00 USD | |
| 02 Feb 2022 | GRANT_AWARD | CytomX Therapeutics, Inc. | 135,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 27 Jul 2017.